You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 6, June 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Altered Carbohydrate Metabolism During Treatment With Lithium Carbonate

Absence of Diagnostic Specificity in Hospitalized Psychiatric Patients

Baron Shopsin, MD; Steven Stern, MD; Samuel Gershon, MD

Arch Gen Psychiatry. 1972;26(6):566-571.


Abstract

Hospitalized psychiatric patients with both affective and non-affective disorders were given oral glucose tolerance tests (GTT) before and after subacute treatment with lithium carbonate. Increased mean blood glucose levels were noted after lithium carbonate treatment in all diagnostic categories and reached statistical significance at the 60-minute interval of the GTT. There was no consistent correlation between clinical course and decreased glucose tolerance in any patient. Other patients were given single lithium carbonate loads; their blood glucose levels showed significant elevation 30 minutes after lithium carbonate ingestion. As with subacute administration, this increase was independent of psychiatric diagnosis. Implications are that decreased glucose tolerance accompanying lithium carbonate administration is due to a physiological effect of this ion and not related to psychiatric diagnosis or change in clinical state during treatment with this drug.



Author Affiliations

New York

From the Department of Psychiatry, Neuropsychopharmacology Research Unit, New York University School of Medicine, New York.


Footnotes

Accepted for publication Feb 24, 1972.

Reprint requests to Department of Psychiatry, New York University Medical Center, 550 First Ave, New York 10016 (Dr. Shopsin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Serum Cholesterol Level and Mortality Due to Suicide and Trauma in the Honolulu Heart Program
Iribarren et al.
Arch Intern Med 1995;155:695-700.
ABSTRACT  

Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats
Honchar et al.
Science 1983;220:323-325.
ABSTRACT  

Differentiation of Depressive Subtypes by Insulin Insensitivity in the Recovered Phase
Lewis et al.
Arch Gen Psychiatry 1983;40:167-170.
ABSTRACT  

Side Effects Associated With Lithium Therapy
Reisberg and Gershon
Arch Gen Psychiatry 1979;36:879-887.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.